
    
      Research purposes:

        1. To investigate the efficacy and safety of SCCCG-BL/DLBCL-2017 in children with BL and
           DLBCL.

        2. To investigate the effect of rituximab combined with chemotherapy on the survival rate
           of children with high-risk BL/DLBCL.

        3. To investigate the effect of rituximab on immune function in children with high-risk
           BL/DLBCL.

        4. To explore the correlation between MRD detection and the efficacy and survival of
           children with BL/DLBCL.

        5. To explore the role of PET/CT in evaluating residual lesions in children after BL/DLBCL
           treatment.
    
  